Michigan

Psychedelic trials in Michigan

13 registered trials has a study site in Michigan, and 3 are recruiting now.

13

Trials with a site here

3

Recruiting

9

Facilities

Open now

Recruiting in this state

Trial	Status	Phase	Substance	Sites
PCORI Comparative Effectiveness Study-Esketamine (Spravato) vs. Ketamine-Equivalence StudyNCT06713616 · Yale University	Recruiting	Phase 3	ketamine	8
Ketamine-assisted Integrative Treatment for Veterans With Chronic Low Back Pain and Comorbid DepressionNCT06419439 · VA Office of Research and Development	Recruiting	Phase 2	ketamine	1
The OBSERVE ProtocolNCT06725277 · Yale University	Recruiting	N/A	ketamine	8

Facilities

Where the research happens in Michigan

Facility	City	Trials
University of Michigan	Ann Arbor	4
VA Ann Arbor Healthcare System, Ann Arbor, MI	Ann Arbor	1
Rochester Center for Behavioral Medicine (RCBM)	Rochester Hills	1
Michigan Clinical Research Institute PC	Ann Arbor	1
University Of Michigan Comprehensive Depression Center	Ann Arbor	1
Ann Arbor VA Medical Center	Ann Arbor	1
Clinical Site 151	Dearborn Heights	1
Chronic Pain and Fatigue Research Center	Ann Arbor	1
Delphinus Medical Technologies, Inc.	Novi	1

Stay told

When a trial opens in Michigan

All trials

Every trial with a Michigan site

Trial	Status	Phase	Substance	Sites
PCORI Comparative Effectiveness Study-Esketamine (Spravato) vs. Ketamine-Equivalence StudyNCT06713616 · Yale University	Recruiting	Phase 3	ketamine	8
Ketamine-assisted Integrative Treatment for Veterans With Chronic Low Back Pain and Comorbid DepressionNCT06419439 · VA Office of Research and Development	Recruiting	Phase 2	ketamine	1
The OBSERVE ProtocolNCT06725277 · Yale University	Recruiting	N/A	ketamine	8
A Study of Esketamine Nasal Spray, Administered as Monotherapy, in Adult Participants With Treatment-resistant DepressionNCT04599855 · Janssen Research & Development, LLC	Completed	Phase 4	ketamine	54
The BIO-K Study: A Single-Arm, Open-Label, Biomarker Development Clinical Trial of Ketamine for Non-Psychotic Unipolar Major Depression and Bipolar I or II Depression.NCT03156504 · Mayo Clinic	Completed	Phase 4	ketamine	4
Efficacy, Safety, and Tolerability of Two Administrations of COMP360 in Participants With TRDNCT05711940 · COMPASS Pathways	Active, not recruiting	Phase 3	psilocybin	116
A Study of Intranasal Esketamine Plus an Oral Antidepressant for Relapse Prevention in Adult Participants With Treatment-resistant DepressionNCT02493868 · Janssen Research & Development, LLC	Completed	Phase 3	ketamine	155
A Long-term Safety Study of Esketamine Nasal Spray in Treatment-resistant DepressionNCT02782104 · Janssen Research & Development, LLC	Completed	Phase 3	ketamine	173
Ketamine Infusion for Comorbid PTSD and Chronic PainNCT04322968 · VA Ann Arbor Healthcare System	Completed	Phase 3	ketamine	1
A Study of CLE-100 (Oral Esketamine) in Addition to Standard Antidepressant Drug for Major Depressive Disorder - CLEO StudyNCT04103892 · Clexio Biosciences Ltd.	Completed	Phase 2	ketamine	46
A Double-blind Study to Assess the Efficacy and Safety of Intranasal Esketamine for the Rapid Reduction of the Symptoms of Major Depressive Disorder, Including Suicidal Ideation, in Participants Who Are Assessed to be at Imminent Risk for SuicideNCT02133001 · Janssen Research & Development, LLC	Completed	Phase 2	ketamine	14
Open-label Study to Assess the Safety and Efficacy of Psilocybin With Psychotherapy in Adult Participants With FibromyalgiaNCT05128162 · Kevin Boehnke	Completed	Phase 2	psilocybin	1
Delphinus SoftVue™ ROC Reader Study (DMT SV RRS3)NCT04260620 · Delphinus Medical Technologies, Inc.	Completed	N/A	dmt	1

Site locations from ClinicalTrials.gov API v2, data build 2026-08-25.

Elsewhere

Other states